Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Candace S Johnson

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|May 9, 2006
Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patientsJosephia R Muindi, Yibing Peng, John W Wilson, et al.
Investigational New Drugs|July 28, 2010
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumorsRajul K Jain, Donald L Trump, Merrill J Egorin, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 21, 2007
CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell linesJosephia R Muindi, Alain Nganga, Kristie L Engler, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2009
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumorsJosephia R Muindi, Candace S Johnson, Donald L Trump, et al.
Journal of Clinical Pharmacology|September 5, 2003
A limited sampling method for the estimation of serum calcitriol area under the curve in cancer patientsJosephia R Muindi, John W Wilson, Ying Peng, et al.
Cancer|July 27, 2012
Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferolYingyu Ma, Wei-Dong Yu, Bing Su, et al.
Cell Cycle (Georgetown, Tex.)|February 8, 2013
Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model systemYingyu Ma, Wei-Dong Yu, Alejandro A Hidalgo, et al.
Oncology|January 24, 2007
Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosisGeraldine Flynn, Ivy Chung, Wei-Dong Yu, et al.
Molecular Cancer Therapeutics|September 16, 2008
1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma modelYingyu Ma, Wei-Dong Yu, Pamela A Hershberger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 21, 2007
Altered VDR-mediated transcriptional activity in prostate cancer stromaAlejandro A Hidalgo, Roberto Paredes, Victor M Garcia, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|May 9, 2006
Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patientsJosephia R Muindi, Yibing Peng, John W Wilson, et al.
Investigational New Drugs|July 28, 2010
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumorsRajul K Jain, Donald L Trump, Merrill J Egorin, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 21, 2007
CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell linesJosephia R Muindi, Alain Nganga, Kristie L Engler, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2009
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumorsJosephia R Muindi, Candace S Johnson, Donald L Trump, et al.
Journal of Clinical Pharmacology|September 5, 2003
A limited sampling method for the estimation of serum calcitriol area under the curve in cancer patientsJosephia R Muindi, John W Wilson, Ying Peng, et al.
Cancer|July 27, 2012
Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferolYingyu Ma, Wei-Dong Yu, Bing Su, et al.
Cell Cycle (Georgetown, Tex.)|February 8, 2013
Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model systemYingyu Ma, Wei-Dong Yu, Alejandro A Hidalgo, et al.
Oncology|January 24, 2007
Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosisGeraldine Flynn, Ivy Chung, Wei-Dong Yu, et al.
Molecular Cancer Therapeutics|September 16, 2008
1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma modelYingyu Ma, Wei-Dong Yu, Pamela A Hershberger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 21, 2007
Altered VDR-mediated transcriptional activity in prostate cancer stromaAlejandro A Hidalgo, Roberto Paredes, Victor M Garcia, et al.
Pageof 11